Middle income vs Saint Kitts and Nevis: Immunization, Hib3
Immunization, Hib3 over time
- Middle income
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 97.0% against 77.1% in Middle income, a difference of 19.9%.
That makes Saint Kitts and Nevis's figure about 1.3 times Middle income's.
Across all 25 years both countries report, Saint Kitts and Nevis has been ahead every year.
Middle income ranks 26th and Saint Kitts and Nevis ranks 29th of 43 groups.
Saint Kitts and Nevis has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle income | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.2% | 89.1% | 74.9% | Saint Kitts and Nevis |
| 2010s | 52.3% | 97.2% | 44.9% | Saint Kitts and Nevis |
| 2020s | 73.4% | 96.8% | 23.4% | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Middle income or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 97.0% against 77.1% in Middle income as of 2024.
- What is the difference in immunization, hib3 between Middle income and Saint Kitts and Nevis?
- 19.9%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Middle income and Saint Kitts and Nevis?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle income and Saint Kitts and Nevis rank globally for immunization, hib3?
- Middle income ranks 26th and Saint Kitts and Nevis ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.